Howard J. West, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy
Dr. West graduated from Harvard Medical School and studying on a Fulbright Scholarship, he received a degree in Experimental Biology from Cambridge University in the United Kingdom. Dr. Howard West studied as an intern and resident at Brigham and Women’s Hospital Boston affiliated to Harvard University. Since 2002 Dr. West has been practicing at the Swedish Cancer Institute with a specialty in lung cancer. He completed his specialty training in mesothelioma at the University of Washington Fred Hutchinson Cancer Research Center. Practicing at one of the country’s most respected cancer research institutes, Dr. West has helped develop very efficient treatment methods for lung cancer.
Harvard Medical School
Medical School
Brigham and Womens Hospital
Internship
University Of Washington School Of Medicine
Residency
Fred Hutchinson Cancer Center
Fellowship
American Board of Internal Medicine - Oncology
Swedish Cancer Institute - Seattle
Languages: English/Spanish
(206) 386-2354
1221 Madison St
Read MoreExtra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations
Stewart DJ1, Martin-Ucar AE, Edwards JG, West K, Waller DA.
See more >>Presentation of HOG Lun 01-24 / USO-023 on the Prescribing Plans of American Medical Oncologists for Patients with Stage IIIB Non-small Cell Lung Cancer
Green, MR.West H, & Socinski, MA. Impact of the ASCO 2007 . J Thor Oncol 2009; 4: 983-987.
See more >>Histologic considerations for individualized systemic therapy approaches for the management of non-small cell lung cancer.
West H, Harpole D, & Travis W.CHEST, 2009: 136; 1112-1118
See more >>Gemcitabine and pemetrexed administered in rapid sequence as front-line chemotherapy for advanced non-small cell lung cancer
West HL, Wakelee HA, Perry MC, Belt RJ, Chen R, & Obasaju C. : A phase II clinical trial. Annals of Oncology 2009; 20: 850 -856
See more >>American Society of Clinical Oncology
Society of Critical Care Medicine
Southwestern Oncology Group